Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial Reply

doi:10.1001/jamaoncol.2022.0491

HFCAS OpenIR

	Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial Reply
	Yu, Yang 1; Zong, Xiangyun 2
	2022-04-14
发表期刊	JAMA ONCOLOGY
ISSN	2374-2437
通讯作者	Zong, Xiangyun(tigerzong@msn.com)
DOI	10.1001/jamaoncol.2022.0491
收录类别	SCI
语种	英语
WOS研究方向	Oncology
WOS类目	Oncology
WOS记录号	WOS:000782627500007
出版者	AMER MEDICAL ASSOC
引用统计
文献类型	期刊论文
条目标识符	http://ir.hfcas.ac.cn:8080/handle/334002/128552
专题	中国科学院合肥物质科学研究院
通讯作者	Zong, Xiangyun
作者单位	1.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China 2.Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 6, Dept Breast Surg, 600 Yishan Rd, Shanghai 200233, Peoples R China
推荐引用方式 GB/T 7714	Yu, Yang,Zong, Xiangyun. Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial Reply[J]. JAMA ONCOLOGY,2022.
APA	Yu, Yang,&Zong, Xiangyun.(2022).Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial Reply.JAMA ONCOLOGY.
MLA	Yu, Yang,et al."Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial Reply".JAMA ONCOLOGY (2022).